文献速递眼底病与葡萄膜炎

年龄相关性黄斑变性家族史与遗传学在调整黄斑状态、人口学及生活方式因素后预测进展为晚期年龄相关性黄斑变性

Family History of Age-Related Macular Degeneration and Genetics Predict Progression to Advanced Age-Related Macular Degeneration Adjusting for Macular Status, Demographic, and Lifestyle Factors.
PubMed 文献 · Am J Ophthalmol · 2023-07-10

这项前瞻性纵向队列研究纳入4910只眼,评估年龄相关性黄斑变性(AMD)家族史和遗传变异在控制基线人口学、行为因素及黄斑状态后,是否可识别进展为晚期AMD(AAMD)的高风险眼。结果显示,1名家族成员相比无家族成员进展风险HR为1.21,≥2名家族成员相比无家族成员HR为1.55;结合非遗传与显著遗传因素的复合风险评分预测进展的AUC为0.92。

要点

  • AMD家族史独立预测进展:1名家族成员HR 1.21,≥2名家族成员HR 1.55。
  • 复合风险评分(含遗传与非遗传因素)预测AAMD的AUC为0.92。
  • 复合评分优于仅含眼部变量的模型:NRI=0.34,ΔAUC 0.05±0.005。

核心结论

  • 在控制基线黄斑状态和其他协变量后,遗传变异和家族史为预测进展为AAMD提供了额外区分能力。

研究设计与样本

  • 前瞻性纵向队列研究,共纳入4910只眼,随访12年,863只眼进展为AAMD。
  • 使用年龄相关性眼病研究严重程度量表对眼进行分类,采用以眼为分析单位的Cox比例风险模型计算风险比(HR),并考虑数据相关性。
  • 通过C统计量和净重分类改善(NRI)评估进展眼与非进展眼的区分能力。

主要发现

  • 基线AMD严重程度量表和对侧眼状态是重要预测因素;基因提供了额外区分能力。
  • AMD家族史在考虑遗传和其他协变量后独立预测进展:1名家族成员 vs 无(HR 1.21 [95%CI 1.02-1.43];P=0.03);≥2名家族成员 vs 无(HR 1.55 [95%CI 1.26-1.90];P<0.001)。
  • 使用非遗传和显著遗传因素β估计值计算的复合风险评分预测进展为AAMD(HR 5.57;第90百分位 vs 第10百分位;AUC=0.92),拟合优于其他模型,包括仅含眼部变量的模型(NRI=0.34;P<0.001;AUC=0.87,ΔAUC 0.05±0.005;P<0.001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To determine if a family history of age-related macular degeneration (AMD) and genetic variants identify eyes at higher risk for progression to advanced AMD (AAMD), after controlling for baseline demographics, behavioral factors, and macular status. DESIGN: Prospective, longitudinal cohort study. METHODS: Eyes were classified using the Age-Related Eye Disease Study severity scale. Non-genetic and genetic predictors for progression to AAMD, geographic atrophy, and neovascular disease were evaluated. Cox proportional hazards models using the eye as the unit of analysis were used to calculate hazard ratios (HRs), accounting for correlated data. Discrimination between progressing and non-progressing eyes was assessed using C-statistics and net reclassification improvement (NRI). RESULTS: Among 4910 eyes, 863 progressed to AAMD over 12 years. Baseline AMD severity scale and status of the fellow eye were important predictors; genes provided additional discrimination. A family history of AMD also independently predicted progression after accounting for genetic and other covariates: 1 family member versus none (HR 1.21 [95% confidence interval {CI} 1.02-1.43]; P = 0.03); ≥2 family members versus none (HR 1.55 [95% CI 1.26-1.90]; P < 0.001). A composite risk score calculated using β estimates of both non-genetic and significant genetic factors predicted progression to AAMD (HR 5.57; 90th vs 10th percentile; area under the receiver operating characteristic curve [AUC] = 0.92), providing superior fit compared with other models, including one with only ocular variables (NRI = 0.34; P < 0.001; AUC = 0.87, ΔAUC 0.05 ± 0.005; P < 0.001). CONCLUSION: Genetic variants and family history provided additional discrimination for predicting progression to AAMD, after accounting for baseline macular status and other covariates.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Seddon JM, De D, Rosner B, et al. Family History of Age-Related Macular Degeneration and Genetics Predict Progression to Advanced Age-Related Macular Degeneration Adjusting for Macular Status, Demographic, and Lifestyle Factors. Am J Ophthalmol. 2023. PMID: 37437830. doi:10.1016/j.ajo.2023.06.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。